drugset / Trial / NCT06261203

Low Dose Aspirin for Prevention of Early Pregnancy Loss

NCT06261203

Unknown 250 enrolled Egymedicalpedia
RandomizedParallel-groupDouble-blindPrevention

Summary

Preeclampsia is a pregnancy-specific, multisystem disorder affecting 3% to 8% of pregnancies and remains a significant cause of maternal and neonatal morbidity and mortality worldwide. The World Health Organization estimates that approximately 76,000 maternal deaths annually are attributed to preeclampsia, accounting for 16% of global maternal mortality, with the majority occurring in low- and middle-income countries

Timeline

Start
2023-07-01
Primary completion
2025-07-01
Completion
2025-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 81 mg

Indications